Ansun BioPharma, Inc., a San Diego based biotechnology company focused on the development of novel broad spectrum anti-v...
Allium Medical, an Israeli medical device company that specializes in minimally invasive technologies and solutions, rec...
A three-day conference on China and U.S. health policy and healthcare wrapped up at Yale University on Sunday. The conf...
A team of esearchers from the Hong Kong Polytechnic University (PolyU) has developed a lens that may slow down the progr...
Unisound, a China based artificial intelligence (AI) and voice recognition company, recently announced a $100 milli...
Ascletis Pharma is the first biotech Chinese firm to apply to hold an initial public offering (IPO) in Hong Kong after r...
Global drug giant AstraZeneca has entered into an agreement with China’s Luye Pharma (Luye Pharma) for the sale an...
WuXi AppTec Co., Ltd., a leading global pharmaceutical and medical device open-access capability and technology platform...
STA Pharmaceutical Co., Ltd., (WuXi STA), announces that its active pharmaceutical ingredient and manufacturing facility...
China has removed import duties on as many as 28 medicines, including all cancer drugs, from May 1, a move which would h...
Refuge Biotechnologies, Inc., a cell therapy company based in California bay area leveraging gene engineering technologi...
Researchers at The Hong Kong University of Science and Technology (HKUST) have identified for the first time the culprit...
Venture capital firm GGV Capital has led a RMB100 million ($15.7 million) series B round in Shanghai-based artificial in...
Australia based Cellmid has recently announced that its wholly owned subsidiary Advangen Limited (“Advangen”...
WuXi Biologics is set to invest $392 million to build a new biologics drug substance manufacturing facility in Ireland. ...
Leading biotech company in China, Innovent Biologics has announced the completion of its $150 million Ser...
Zoetis Inc. recently started the construction of a combined global manufacturing and supply and research and development...
STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec (WuXi STA), has signed an investment agreement with the govern...
Werfen, a global leader in healthcare and life sciences, achieves revenues of 1,337 million euros in 2017, a 1...
Foundation Medicine, Inc. (FM), F. Hoffmann-La Roche Ltd (Roche) and DIAN Diagnostics Group, Co., Ltd. (DIAN), have anno...
Singapore – Shanghai-based Zai Lab Limited inks an exclusive license agreement with privately held Entasis Therape...
MilliporeSigma, a leader in genome editing, has announced that the Chinese Patent Office has issued a notice granting Mi...
Singapore- Tocagen enters into a license agreement with ApolloBio affiliate Beijing Apollo Venus Biomedical Te...
Prenetics, a HongKong-based genetic testing and digital health company, has announced acquisition of DNAFit, a UK-based ...
Sinovac Biotech, a leading provider of biopharmaceutical products in China, has announced preliminary results of a phase...
WuXi AppTec is a leading global pharmaceutical and medical device open-access capability and technology platform company...
JHL Biotech recently announced that the China Food and Drug Administration (CFDA) have accepted for review JHL's Clinica...
Royal Philips, a global leader in health technology, and Digital China Health, the largest provider of cloud-based healt...
AK Medical Holdings, a Beijing orthopedic implant maker, has paid $24 million to acquire JRI Orthopedics, UK.&...
CMB International Capital Corporation Ltd, a wholly-owned subsidiary of China Merchants Bank, recently led a $65 million...
Morphotek Inc., a subsidiary of Eisai Inc., has licensed its eribulin-linker payload to Bliss Biopharmaceutical Co., Ltd...
China-based BeiGene, , a commercial-stage biopharmaceutical company focused on developing and commercializing inno...
Ubiquigent Limited has entered into a multi-year strategic R&D collaboration agreement with FORMA Therapeutics for t...
CICC Capital Management Company Limited, a wholly-owned subsidiary of China International Capital Corporation Limited (C...
Eli Lilly has offloaded three small molecule therapeutic candidates for the potential treatment of non-alcoholic steatoh...
Equashield a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, announced that it will be l...
China based CMAB Biopharma Inc. (CMAB), a full-service contract development and manufacturing organization (CDMO) provid...
Nabriva Therapeutics, a clinical stage biopharmaceutical company engaged in the research and development of novel anti-i...
Fresenius Medical Care, the world's largest provider of dialysis products and services, has announced a new partnership ...
Hua Medicine, a clinical-stage drug development company developing novel therapies for the treatment of Type 2 diabetes,...
Singlera Genomics, a non-invasive genetic diagnostics company that focuses on early-stage cancer detection, has succ...
Boehringer Ingelheim (BI) has teamed up with two China animal health companies, Beijing KangMu Omni-Hones...
Allergan plc announces the launch of Ozurdex® (dexamethasone intravitreal implant 0.7 mg) in China for the treatment...
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...
Inovio Pharmaceuticals, today announced that it has inked an agreement providing ApolloBio with the exclusive right to d...
Akonni Biosystems Inc. and Chinese in vitro diagnostics company, Righton, recently announced a commercial agreement that...
Dova Pharmaceuticals, Inc. has entered into an agreement through its wholly owned subsidiary, AkaRx, Inc., granting Shan...
Loncar Investments, LLC has recently announced the launch of the Loncar China BioPharma Index (LCHINA), the world&r...
PierianDx, the leading genomics technology company that enables precision medicine programs and molecular testing for he...
Chinese scientists have developed an artificial heart using rocket technology and it is currently undergoing testing aft...
Taiwan-based United Biopharma (UBP) has recently partnered with GE Healthcare Life Sciences to build a biologics facilit...
A consortium of leading global investors including Temasek and Sequoia Capital China has joined the $90-millio...
Shanghai based diabetes drug developer, Hua Medicine has picked Hong Kong over the U.S. for its initial public offe...
China based WuXi Biologics has entered into a collaboration with Adagene Inc. to support supply of Adagene's products fo...
MicuRx Pharmaceuticals announced the Global Partnership Program " Combating Antibiotic Resistant Bacteria Accelerator" (...
Chengdu-based consumer genetic testing startup 23Mofang has raised Rmb100 million ($15.8 million) in a Series B funding ...
WuXi Biologics, a Hong Kong-listed company, received Asia's CMO of 2017 at the 8th Annual BioPh...
The Hong Kong Polytechnic University (PolyU) has joined forces with the Fraunhofer-Gesellschaft (Fraunhofer) and the Kar...
Tianjin, China based Tasly Pharmaceutical Group is planning to list its biopharma unit in Hong Kong to raise about $1 bi...
China based CARsgen Therapeutics, a leading immune-oncology company focusing on the development of CAR-T therapies, has ...
Chinese e-commerce giant Alibaba has opened its first joint research institute outside China in Singapore, in a collabor...
Early stage Chinese bispecific biotech EpimAb Biotherapeutics has roped in Bin Peng, M.D., Ph.D, as its first chief medi...
Hong Kong Science and Technology Parks Corporation (HKSTP) plans to focus on biotechnology and artificial intelligence a...
MabSpace is a global biotechnology company focused on discovering and developing innovative antibody therapeutics using ...
Alma Lasers, a subsidiary of Sisram Medical Ltd the leading global innovator of laser light-based, radiofrequency and ul...
A WuXi AppTec group company, STA Pharmaceutical Co., the leading open-access capability and technology platform for smal...
Two institutes from Ethiopia and China have signed a memorandum of understanding (MoU) on scientific and technological c...
Tetraphase Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing novel antibiotic...
The biopharmaceutical company Mologen recently announced the signing of a license deal for the Chinese territory and a g...
China’s state-controlled drugmaker Harbin Pharmaceutical Group Holding Co plans to buy an about 40 percent st...
Industry veteran, Michael Glynn, has joined CANbridge Life Sciences' advisory team, where he will provide lead...
Healthcare investment firm Vivo Capital led the $55 million funding round of Beijing Innocare, a biopharmaceutical compa...
US based Biostage Inc., a biotechnology company developing bioengineered organ implants to treat life-threatening condit...
Tsinghua University Holdings (TUS) of Beijing is planning to invest $276 million to build a new biohub in the UK's Cambr...
American clinical stage biopharmaceutical company Rexahn Pharmaceuticals, Inc. has entered into collaboration with China...
Bangkok hosting Asia’s largest event ‘ProPak Asia’ which include the entire food, drink, and pharma pr...
Merck, a leading science and technology company, will celebrate its 350th anniversary this year with customers, partners...
Looking at China’s increasing zeal for improving biotechnology and medical services, the British government has ma...
China based biotechnology company NetVation DL Medicine has entered into a two-year research collaboration with Pfizer I...
China-US biopharma, Cellular Biomedicine recently announced a $30.6 million investment from Shanghai-Hong Kong PE invest...
ChineseInvestors.com, Inc., the premier financial information website for the Chinese-speaking investors, announced that...
Hong Kong Polytechnic University (PolyU) has announced a biotechnology and translational medicine collaboration program ...
Cardinal Health has announced the closing of its divestiture of its Cardinal Health China business to Shanghai Pharm...
A leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery...
China’s Sinobioway Group has inked an deal worth over C$125M with Canada’s Enerkem Inc in the for...
A team of scientists from National Center for NanoScience and Technology, Beijing, China, in cooperation with medical sc...
Shanghai-based digital health startup targeting the insurance market, CareVoice has raised $2 million in early-stage fun...
CBMG is Cellular Biomedicine Group which develops proprietary cell therapies for the treatment of cancer and degenerativ...
WuXi NextCODE, the emerging global standard platform for genomic data, announced a partnership with Rhythm Pharmaceutica...
Eisai Co., Ltd. announced that its Chinese subsidiary, Eisai China Inc. (ECI) has completed construction of a new oral s...
BioAtla, a global biotechnology company focused on the development of Conditionally Active Biologic (CAB) protein therap...
Cantargia is a biotech company that is developing antibody-based treatments for life-threatening diseases. The company'...
China-based company, HaploX that focuses on precision medicine and genetic data has closed a $32 million Series A-plus f...
Inovio Pharmaceuticals, today announced that it entered an amended agreement providing ApolloBio Corporation ...
Hunan Province-based biotechnology firm Sansure Biotech has raised $77 million from a group of investors led by Lilly As...
In a move towards documenting the genetic makeup of one lakh people to help generate the precision medicines for the fut...
vTv Therapeutics, a US-based a clinical-stage biopharmaceutical company has inked a licensing deal with China’s Ha...
Announcement is done by Janssen Pharmaceutical Company of Johnson & Johnson that it has entered into a worldwide col...
Jacobson Medical and Joyful Ascent Limited, subsidiaries of Jacobson Pharma Corporation Limited have entered into a Lice...
A group of researchers at Harvard University have designed a system that aligns financial incentives for physicians and ...
